A clinical study of the safety and the curability of laparoscopic total gastrectomy for advanced gastric cancer

A clinical study of the safety and the curability of laparoscopic total gastrectomy for advanced gastric cancer - A clinical study of the safety and the curability of laparoscopic total gastrectomy for advanced gastric cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027649

Enrollment

100

Registered

2017-07-01

Start date

2018-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cander

Interventions

Laparoscopic total gastrectomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Histologically proven gastric adenocarcinoma. 2) Diagnosed cStage II or III by endoscopy and CT. 3) Tumor located in the upper third of the stomach, and curative resection is expected to be achievable by total gastrectomy. 4) Age: 20-90. 5) ECOG performance status 0-1. 6) Sufficient organ functions. 7) Written informed consent obtained from patients.

Exclusion criteria

Exclusion criteria: 1) Pregnant or lactating female. 2) Patients with psychiatric disease or severe mental symptoms. 3) Patients with uncontrollable hypertension. 4) Patients with uncontrollable diabetes. 5) Other patients evaluated to be inadequate to participate in this study by investigators.

Design outcomes

Primary

Measure	Time frame
anastomotic leakage, pancreatic fistula and intra-abdominal abscess	—

Countries

Japan

Contacts

Public ContactToshiro Tanioka

Tokyo Medical and Dental University Hospital Department of Gastric Surgery

tanioka.srg1@tmd.ac.jp+81-3-5803-5260

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026